174 related articles for article (PubMed ID: 37079118)
1. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
[TBL] [Abstract][Full Text] [Related]
2. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
He L; Lv S; Ma X; Jiang S; Zhou F; Zhang Y; Yu R; Zhao Y
Med Oncol; 2022 Jan; 39(4):45. PubMed ID: 35092510
[TBL] [Abstract][Full Text] [Related]
3. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
4. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
5. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of SCD1 by ErbB2 via LDHA promotes breast cancer cell migration and invasion.
Chen J; Lv S; Huang B; Ma X; Fu S; Zhao Y
Med Oncol; 2022 Dec; 40(1):40. PubMed ID: 36471172
[TBL] [Abstract][Full Text] [Related]
7. Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer.
Guo Y; Liang F; Zhao F; Zhao J
Mol Cell Biochem; 2020 Mar; 466(1-2):103-115. PubMed ID: 32006291
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
9. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
10. DDX24 promotes tumor progression by mediating hexokinase-1 induced glycolysis in gastric cancer.
Ni Y; Zhuang Z
Cell Signal; 2024 Feb; 114():110995. PubMed ID: 38043669
[TBL] [Abstract][Full Text] [Related]
11. [Knockdown of hexokinase 2 (HK2) inhibits breast cancer cell proliferation and reduces their resistance to fluorouracil].
Wang J; Tao M; Wang T; Wang Z; Xiao J; Ding S; Chen R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Aug; 37(8):722-727. PubMed ID: 34236032
[TBL] [Abstract][Full Text] [Related]
12. Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin.
Xu S; Catapang A; Doh HM; Bayley NA; Lee JT; Braas D; Graeber TG; Herschman HR
J Nucl Med; 2018 Jun; 60(2):212-7. PubMed ID: 29880505
[TBL] [Abstract][Full Text] [Related]
13. An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1
Xu S; Zhou T; Doh HM; Trinh KR; Catapang A; Lee JT; Braas D; Bayley NA; Yamada RE; Vasuthasawat A; Sasine JP; Timmerman JM; Larson SM; Kim Y; MacLeod AR; Morrison SL; Herschman HR
Cancer Res; 2019 May; 79(10):2748-2760. PubMed ID: 30885978
[TBL] [Abstract][Full Text] [Related]
14. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Patra KC; Wang Q; Bhaskar PT; Miller L; Wang Z; Wheaton W; Chandel N; Laakso M; Muller WJ; Allen EL; Jha AK; Smolen GA; Clasquin MF; Robey B; Hay N
Cancer Cell; 2013 Aug; 24(2):213-228. PubMed ID: 23911236
[TBL] [Abstract][Full Text] [Related]
15. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
Kang M; Lee SM; Kim W; Lee KH; Kim DY
Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
[TBL] [Abstract][Full Text] [Related]
16. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
[TBL] [Abstract][Full Text] [Related]
17. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
Cancer Metab; 2018; 6():7. PubMed ID: 29988332
[TBL] [Abstract][Full Text] [Related]
18. Spermatogenic cell-specific type 1 hexokinase is the predominant hexokinase in sperm.
Nakamura N; Shibata H; O'Brien DA; Mori C; Eddy EM
Mol Reprod Dev; 2008 Apr; 75(4):632-40. PubMed ID: 17924400
[TBL] [Abstract][Full Text] [Related]
19. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
Hui L; Zhang J; Guo X
Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
[TBL] [Abstract][Full Text] [Related]
20. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
